Respiratory Deposition Patterns of Salbutamol pMDI with CFC and HFA-134a Formulations in a Human Airway Replica
- 1 June 2001
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Aerosol Medicine
- Vol. 14 (2) , 255-266
- https://doi.org/10.1089/08942680152484180
Abstract
This paper describes a technique that uses a well-defined human airway replica and gamma counting as a standard method for evaluating and comparing the performance of medical inhalers and spacers. High-fidelity replicas reproduced as needed from master casts made from human cadavers include the oropharyngeal cavity, larynx, trachea, and five to nine generations of bronchi. Deposition in the small airways and alveoli region of the cast is simulated by material that passes through the upstream airways and is collected on foam filters. Deposition patterns in the respiratory tract replica were obtained by using radiolabel in the medical inhaler and by gamma scintigraphy. This technique was used to determine respiratory deposition patterns of salbutamol in a pressurized metered dose inhaler (pMDI) with chlorofluorocarbon (CFC, in-house formulation) and HFA-134 formulations (Proventil hydrofluoroalkane [HFA]). At an inspiration flow of 30 L/min, patterns in the salbutamol/CFC formula showed a high deposition in the oropharyngeal airway (78%) and a 16% deposition in the lung, similar to in vivo measurements reported in the literature. However, the salbutamol/HFA formula showed lower oral deposition (56%) but higher lung deposition (24%). The difference in the oral deposition patterns may be attributed to lower initial spray velocity, initial droplet evaporation rate, and possibly initial droplet sizes of Proventil HFA. The small orifice diameter (0.25 mm) of the Proventil HFA actuator produced a softer plume with a smaller impact force, resulting in lower oropharyngeal deposition. Cascade impactor measurements showed similar aerodynamic particle size distribution of the CFC and HFA formulations. We also showed that using spacers in the Proventil HFA resulted in a lower oropharyngeal deposition and higher lung deposition, indicating beneficial effects. Comparison of oropharyngeal deposition and those predicted by artificial throats used in the impactor measurements showed that, in general, the artificial throat predicted a lower deposition.Keywords
This publication has 26 references indexed in Scilit:
- A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalersInternational Journal of Pharmaceutics, 1999
- In Vitro Comparison of Salbutamol Hydrofluoroalkane (Airomir) Metered Dose Inhaler Aerosols Inhaled during Pediatric Tidal Breathing from Five Valved Holding ChambersJournal of Aerosol Medicine, 1999
- Advances in Metered Dose Inhaler Technology with the Development of a Chlorofluorocarbon-Free Drug Delivery SystemJournal of Aerosol Medicine, 1999
- Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasoneEuropean Respiratory Journal, 1998
- Early lung absorption profile of non‐CFC salbutamol via small and large volume plastic spacer devicesBritish Journal of Clinical Pharmacology, 1998
- In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devicesEuropean Respiratory Journal, 1997
- Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler.Thorax, 1995
- Pressurised aerosol deposition in the human lung with and without an "open" spacer device.Thorax, 1989
- PARTICLE DEPOSITION WITHIN BRONCHIAL AIRWAYS: COMPARISONS USING CONSTANT AND CYCLIC INSPIRATORY FLOWSAnnals of Work Exposures and Health, 1982
- Particle deposition in a hollow cast of the human tracheobronchial treeJournal of Aerosol Science, 1977